Can a botox shot ease Writer's cramp? new trial tests xeomin
NCT ID NCT03977493
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injections of Xeomin (a botulinum toxin type A) can reduce hand cramps in people with focal hand dystonia, a condition that causes involuntary muscle contractions. About 48 adults will receive either Xeomin or a placebo injection into hand muscles. The main goal is to see if it improves handwriting comfort and ability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IncobotulinumtoxinA (Xeomin)
- What this could lead to
- If it works, this could provide a proven treatment option to reduce hand cramps and improve handwriting for people with focal hand dystonia.
- What could go wrong
- This is a small Phase 3 trial with only 48 participants, so results may not apply to everyone. The effect may be modest, and injections can cause temporary muscle weakness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL HAND DYSTONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier universitaire vaudois (CHUV)
NOT_YET_RECRUITINGLausanne, 1001, Switzerland
-
Inselspital - University Hospital Berne
NOT_YET_RECRUITINGBern, 3010, Switzerland
-
Neurocenter of St. Gallen
NOT_YET_RECRUITINGSankt Gallen, 9007, Switzerland
-
Neurocentro della Svizzera Italiana
RECRUITINGLugano, 6900, Switzerland
-
USZ- Univerity Hospital Zurich
NOT_YET_RECRUITINGZurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.